不确定潜力的克隆性血液形成:对疾病的贡献和有前途的干预措施
Chongjie Li1,2, Chunxiang Zhang3,4, Xiuying Li5,6
1Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China.
Molecular and cellular biochemistry
|March 27, 2025
概括
不确定潜力的克隆性血液形成 (CHIP) 涉及扩大突变血液细胞,增加癌症和心脏病的风险. 炎症是关键因素,提供潜在的治疗点和个性化治疗策略.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 具有随着衰老的血液细胞体细胞突变的扩张的特征.
- CHIP与血液恶性瘤和心血管疾病的风险增加有关.
- 炎症在CHIP相关疾病中发挥着核心作用,并代表着潜在的治疗点.
研究的目的:
- 审查目前对CHIP流行病学和临床意义的理解.
- 探索炎症在CHIP相关疾病风险中的作用.
- 检查链接CHIP,炎症和疾病的机制,并讨论个性化治疗方法.
主要方法:
- 关于CHIP的流行病学研究,临床数据和机制研究的文献综述.
- 分析炎症在CHIP病原和疾病关联中的作用.
- 探索针对CHIP患者炎症的潜在治疗策略.
主要成果:
- 随着年龄的增长,CHIP的患病率会增加,特定突变与风险增加有关.
- 炎症是将CHIP与心血管和其他非恶性疾病联系起来的关键媒介.
- 新出现的证据表明,一些CHIP突变可能具有有益的影响,突出复杂性.
结论:
- CHIP是一种与衰老相关的严重疾病,具有复杂的健康影响,包括风险和潜在益处.
- 针对炎症是管理CHIP相关疾病的一个有希望的途径.
- 个性化医疗方法对于为CHIP患者量身定制疗法至关重要.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Bone Marrow Sampling and Transplants
267
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
267
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K


